Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Offer for Subscription - Update

4 Aug 2021 15:30

RNS Number : 6032H
Amati AIM VCT PLC
04 August 2021
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR SOUTH AFRICA OR ANY JURISDICTION FOR WHICH THE SAME COULD BE UNLAWFUL. THE INFORMATION CONTAINED HEREIN DOES NOT CONSTITUTE AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA.

 

Amati AIM VCT plc

4 August 2021

 

Amati AIM VCT plc (the "Company")

Legal Entity Identifier: 213800HAEDBBK9RWCD25

Offer for subscription - Update

The Board of Amati AIM VCT plc (the "Company") announced on 28 July 2021 that the Company had published a prospectus (the "Prospectus") in connection with proposals to raise up to £40 million (with an over-allotment facility to raise up to a further £25 million), by way of an offer for subscription of new ordinary shares (the "Offer") (the "New Shares").

The Board has been advised that, on the basis of applications received, the Company has successfully raised £40 million under the Offer. The Board does not intend to utilise the over-allotment facility at the current time, but the Investment Manager is closely monitoring potential investment opportunities and, if it is felt appropriate, the Company will seek to raise further funds under the over-allotment facility prior to the Offer closing.

The first allotment of New Shares is expected to be on or around 9 August 2021. Dealings in the New Shares issued under this allotment are expected to become effective on 23 August 2021. The Company is no longer accepting applications in relation to the Offer. Investors whose applications are received after the Company raised £40 million will have their subscription monies returned in accordance with the terms and conditions of the Offer. If the over-allotment facility is to be utilised, the Company will make a further RNS announcement detailing the application process.

For further information, please contact the investor line at Amati Global Investors on 0131 503 9115 or by email at info@amatiglobal.com.

Notes

This announcement does not constitute or form part of any offer to issue or sell, or any solicitation of any offer to subscribe for or purchase, any investment in any jurisdiction, nor shall it (or the fact of its distribution) form the basis of, or be relied on in connection with, any contract therefor.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUPUBPRUPGGCC
Date   Source Headline
6th Dec 20245:00 pmRNSNet Asset Value(s)
3rd Dec 20244:40 pmRNSTransaction in Own Shares
3rd Dec 202410:05 amRNSNet Asset Value(s)
2nd Dec 202411:20 amRNSTotal Voting Rights
2nd Dec 20247:00 amRNSConclusion of Strategic Review & Change of Manager
25th Nov 202410:58 amRNSNet Asset Value(s)
18th Nov 202412:07 pmRNSTransaction in Own Shares
15th Nov 20244:14 pmRNSNet Asset Value(s)
8th Nov 20244:12 pmRNSNet Asset Value(s)
1st Nov 20244:28 pmRNSNet Asset Value(s)
1st Nov 20243:15 pmRNSTotal Voting Rights
30th Oct 20243:34 pmRNSTransaction in Own Shares
29th Oct 20241:26 pmRNSTransaction in Own Shares
28th Oct 20249:36 amRNSNet Asset Value(s)
22nd Oct 20242:05 pmRNSTransaction in Own Shares
21st Oct 20249:50 amRNSNet Asset Value(s)
14th Oct 20243:33 pmRNSTransaction in Own Shares
11th Oct 20244:40 pmRNSNet Asset Value(s)
8th Oct 20244:22 pmRNSTransaction in Own Shares
7th Oct 20241:16 pmRNSNet Asset Value(s)
2nd Oct 202410:36 amRNSNet Asset Value(s)
1st Oct 202410:00 amRNSTotal Voting Rights
27th Sep 20247:00 amRNSHalf-year Report
25th Sep 20243:12 pmRNSTransaction in Own Shares
23rd Sep 202410:28 amRNSNet Asset Value(s)
19th Sep 20249:12 amRNSDividend Declaration
13th Sep 20245:12 pmRNSNet Asset Value(s)
11th Sep 202411:05 amRNSTransaction in Own Shares
6th Sep 20244:57 pmRNSNet Asset Value(s)
4th Sep 20244:35 pmRNSTransaction in Own Shares
3rd Sep 20242:55 pmRNSNet Asset Value(s)
3rd Sep 20247:00 amRNSUpdate on Strategic Review
2nd Sep 202411:13 amRNSCompliance with Market Abuse Regulation
2nd Sep 202411:01 amRNSTotal Voting Rights
23rd Aug 20245:42 pmRNSNet Asset Value(s)
16th Aug 20244:39 pmRNSNet Asset Value(s)
12th Aug 20244:50 pmRNSTransaction in Own Shares
9th Aug 20245:18 pmRNSNet Asset Value(s)
5th Aug 20241:40 pmRNSTransaction in Own Shares
2nd Aug 202410:05 amRNSNet Asset Value(s)
1st Aug 20244:37 pmRNSTransaction in Own Shares
1st Aug 202411:40 amRNSTotal Voting Rights
26th Jul 20243:40 pmRNSNet Asset Value(s)
24th Jul 20242:31 pmRNSTransaction in Own Shares
23rd Jul 20242:45 pmRNSTransaction in Own Shares
22nd Jul 202410:31 amRNSNet Asset Value(s)
15th Jul 20245:16 pmRNSNet Asset Value(s)
8th Jul 202410:40 amRNSNet Asset Value(s)
2nd Jul 202412:02 pmRNSNet Asset Value(s)
1st Jul 20243:50 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.